glp-1/gip receptor agonists New strategies for the treatment of obesity and metabolic dysfunctions Bridging the gap between GLP1-receptor
Description
The most common side effects are gastrointestinal: nausea, fullness, constipation, diarrhea, reflux, and reduced appetite
Cases of weight-loss drug poisoning In 2021, the New Jersey Poison Control Center recorded 29 GLP-1 exposure cases
Fiber increases SCFAs, nourishes Akkermansia and other beneficial microbes, and prevents the metabolic stagnation seen in some GLP-1 users
2022, doi: 10.1016/j.ejmech.2022.114458
Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26) J Immunol
The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis
